First Safety Study in Humans of a Single Dose of CPG 52364

NCT00547014 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo Comparator: Cohort 1 Placebo
DRUG: 52364 3 mg
DRUG: Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo
DRUG: 52364 10 mg
DRUG: 52364 30 mg
DRUG: 52364 100 mg
DRUG: 52364 1 mg

Sponsor

Pfizer